Bronchoalveolar Lavage Cytology in Equine Respiratory Disease

Introduction

Bronchoalveolar lavage (BAL) cytology is a cornerstone diagnostic procedure in equine respiratory medicine. It provides a direct, quantifiable assessment of the cellular milieu of the lower airways, enabling the differentiation of inflammatory, infectious, and fibrotic pulmonary conditions [1]. The technique involves the instillation and subsequent retrieval of sterile isotonic fluid into a lung segment, typically via an endoscope or a blind-catheter technique, to sample the epithelial lining fluid and its cellular constituents [2, 3]. The quantitative and qualitative analysis of these recovered cells forms the basis for diagnosing conditions such as equine asthma (EA), inflammatory airway disease (IAD), equine multinodular pulmonary fibrosis (EMPF), and exercise-induced pulmonary hemorrhage (EIPH) [4, 5, 6, 7]. This article provides an exhaustive reference on the methodologies, cytological interpretation, clinical applications, and limitations of BAL cytology in the context of equine respiratory disease.

Indications and Clinical Context

BAL cytology is indicated in any horse presenting with clinical signs referable to the lower respiratory tract, including chronic cough, exercise intolerance, increased respiratory effort, and abnormal lung sounds on auscultation [5, 8, 9]. It is particularly valuable for distinguishing between the major phenotypes of equine asthma: mild to moderate asthma (often termed IAD) and severe asthma (formerly recurrent airway obstruction, RAO) [5, 9]. The procedure is also critical in the diagnostic workup for EMPF, a progressive interstitial lung disease associated with equine herpesvirus-5 (EHV-5) infection, where BAL cytology typically reveals a mixed inflammatory infiltrate [4, 10]. Furthermore, BAL is utilized to confirm EIPH by detecting erythrocytes and hemosiderophages in the lavage fluid, particularly when endoscopic examination is negative [7, 11]. Additionally, BAL can aid in the diagnosis of bacterial and fungal pneumonia, although the sensitivity for bacterial isolation is variable [12, 35].

Bronchoalveolar Lavage Procedure

The procedure is performed with the horse standing and sedated, using a 1.8 to 2.0 meter endoscope passed nasotracheally or a commercially available BAL catheter [2]. The endoscope or catheter is wedged into a bronchus, typically at the level of the carina. Sterile, warm (37 degrees Celsius) isotonic saline or lactated Ringer's solution is instilled in aliquots (typically 60-100 mL per aliquot), for a total volume of 250-500 mL [6, 3]. The fluid is immediately aspirated or allowed to flow via gravity into a collection container. A good quality BAL sample is characterized by a recovery rate of at least 40-60% of the instilled volume and a frothy appearance from surfactant content [6, 2]. Poor recovery may indicate improper wedging, excessive airway collapse, or severe airway pathology.

Factors Influencing BAL Results

Several factors can influence the quality and representativeness of the BAL sample. Prior administration of corticosteroids or bronchodilators can alter the cellular profile, reducing neutrophil counts and modulating macrophage populations [13, 14, 29]. Exercise immediately before the procedure may increase the proportion of erythrocytes and inflammatory cells, mimicking EIPH or mild inflammation [7, 11]. The seasonality and housing environment also play a role, as pastured horses show different baseline cytological profiles compared to stabled horses [3]. Therefore, a standardized protocol and careful clinical history are essential for reliable interpretation.

Laboratory Processing and Cytological Preparation

Following collection, BAL fluid (BALF) is typically processed within one to two hours. The sample is first assessed macroscopically for color, turbidity, and presence of blood or mucus. A portion is submitted for routine bacterial culture and antimicrobial sensitivity if infection is suspected [35]. For cytological analysis, the fluid is gently mixed and a small aliquot is taken for total nucleated cell count (TNCC) using a hemocytometer or automated impedance analyzer [15].

Preparation Techniques

Two primary methods exist for preparing slides for cytological examination: cytocentrifugation and sediment smear (direct smear) preparations.

Cytocentrifugation involves spinning a small volume (typically 100-200 microliters) of BALF at low speed (e.g., 300-500 rpm for 5 minutes) in a specialized cytocentrifuge. This technique concentrates cells onto a defined area of a glass slide while preserving cellular morphology. It is considered the gold standard for quantitative differential counts due to the uniform cell distribution it provides [6].

Sediment smear preparation involves centrifuging a larger volume of BALF at higher speeds (e.g., 2000 rpm for 10 minutes) to pellet cells, removing the supernatant, resuspending the pellet in a small volume of fluid, and then making a smear. This method can introduce bias, as it may overrepresent inflammatory cells that pellet more efficiently and can lead to excessive cellular distortion and stacking, making differential counts less reliable [6]. Morini et al. (2023) demonstrated that while cytocentrifugation is superior for quantitative differential counts, sediment smears can still be useful for qualitative assessments such as detecting hemosiderophages or rare cellular elements in samples with low cellularity [6].

Normal BAL Cytology

Normal equine BALF contains a predominance of alveolar macrophages (typically 50-80% of total nucleated cells) and lymphocytes (15-40%) [3, 15]. Neutrophils are a minor component, normally comprising less than 5% of the total cell count in healthy horses. Eosinophils and basophils are rarely observed, with their presence often indicative of a parasitic or hypersensitivity response. Mast cells can be present in small numbers (typically <2%). The reference thresholds for normal BALF cellularity are summarized in Table 1 [3, 1].

Table 1: Cytological Reference Ranges for Normal Equine Bronchoalveolar Lavage Fluid

Cytological Patterns in Equine Respiratory Disease

Equine Asthma (EA)

Equine asthma encompasses a spectrum of airway inflammatory diseases with distinct cytological patterns. The two major phenotype groups are based on clinical severity and BAL cellular composition [5, 8].

Mild to Moderate Equine Asthma (IAD): This condition is diagnosed in horses with mild clinical signs such as occasional cough and poor performance. The hallmark BAL cytology finding is a mild increase in inflammatory cells without a dominant neutrophilia. The primary cell types implicated are airway eosinophils and/or mast cells [8, 3, 16]. A commonly used diagnostic criterion is an elevated total nucleated cell count with more than 2% eosinophils or more than 2% mast cells, or a neutrophilia between 5% and 10% [3]. Research by Dupuis-Dowd and Lavoie (2022) showed that in mild to moderate asthma, airway smooth muscle remodelling is present, correlating with the chronicity of inflammation [8].

Severe Equine Asthma (Recurrent Airway Obstruction, RAO): This condition is characterized by severe, recurrent airway obstruction triggered by environmental allergens (e.g., molds, endotoxins from hay). The cytological hallmark is a pronounced neutrophilia, often exceeding 25% and frequently reaching 50-80% of the total nucleated cells [6, 17, 1]. This neutrophilic inflammation is accompanied by increased mucus production, which is visible cytologically as streaming mucus strands often containing entrapped cells [6, 15]. The severity of airway obstruction correlates with the degree of neutrophilic inflammation [1, 18]. The influx of neutrophils is driven by a complex cascade of inflammatory mediators, including cytokines such as IL-8 and TNF-alpha, as well as matrix metalloproteinases [14, 17]. A lipidomic analysis of surfactant and plasma by Christmann et al. (2022) further revealed that severe asthma is associated with distinct alterations in the lipid microenvironment of the airways, which may influence inflammatory signaling [19].

Table 2: Differential Cytological Patterns in Equine Airway Diseases

Equine Multinodular Pulmonary Fibrosis (EMPF)

EMPF is a progressive, fatal interstitial lung disease of adult horses, strongly associated with EHV-5 infection [4, 10]. BAL cytology in EMPF is non-specific but supportive of a diagnosis of interstitial lung disease. Characteristic findings include a mixed inflammatory population with an increased number of macrophages that often have a foamy, vacuolated cytoplasm. There may be a mild to moderate lymphocytosis and neutrophilia [4]. The presence of multinucleated giant cells and fibrocytes (cells with a stellate morphology that are intermediate between fibroblasts and macrophages) is suggestive of EMPF [10]. Diagnosis is often confirmed via histopathology of lung biopsy or post-mortem examination and detection of EHV-5 DNA by PCR on BALF or lung tissue [4, 10].

Exercise-Induced Pulmonary Hemorrhage (EIPH)

EIPH is a common condition in racehorses characterized by bleeding from the pulmonary capillaries into the airways during strenuous exercise. BAL cytology is considered the most sensitive method for detecting EIPH, as it can identify erythrocytes and, more importantly, hemosiderophages (macrophages that have phagocytosed red blood cells) [7, 11]. Hemosiderophages contain intracellular golden-brown granules of hemosiderin, which stain positively with Prussian blue. The presence of hemosiderophages indicates prior hemorrhage, with the number of such cells reflecting the severity and chronicity of the condition [7, 11]. The grading of hemosiderosis in BALF is often semi-quantitative, using a scoring system from 0 to 4 based on the proportion of hemosiderophages present [7].

Bacterial and Fungal Pneumonia

BAL cytology in bacterial pneumonia typically reveals a marked neutrophilia, often with degenerate neutrophils (cells exhibiting pyknotic nuclei and foamy cytoplasm) and intracellular or extracellular bacteria [35]. The presence of bacteria is not definitive, as contamination from the upper airways can occur. However, the predominance of degenerate neutrophils with intracellular bacteria is highly suggestive of active infection [35]. Fungal infections, such as those caused by Aspergillus fumigatus or Rhinosporidium seeberi, are less common. In such cases, cytology may reveal fungal hyphae, spores, or sporangia, often accompanied by a mixed inflammatory response including eosinophils, macrophages, and neutrophils [12, 30]. MacNeill et al. (2003) described a case of Rhodococcus equi pneumonia in a foal where BAL cytology was crucial for identifying the gram-positive coccobacilli within macrophages [35].

Airway Inflammation in Foals

BAL cytology is also utilized in neonatal and foal respiratory diagnostics. Conditions such as aspiration pneumonia, sepsis, and viral infections produce characteristic inflammatory patterns [2, 17]. In foals with pneumonia, a neutrophilic inflammation with or without intracellular bacteria is typically seen [35]. The procedure is more technically challenging in foals due to their smaller airway diameter, but it remains a valuable tool for guiding antimicrobial therapy.

Integration with Other Diagnostic Modalities

BAL cytology is rarely interpreted in isolation. It is best integrated with the complete clinical picture, including history, physical examination findings, endoscopic airway scoring, and advanced pulmonary function testing (e.g., impulse oscillometry, barometric whole-body plethysmography) [1, 20, 33]. Thoracic radiography can reveal patterns of interstitial or bronchial disease consistent with EMPF or chronic asthma, while thoracic ultrasonography aids in detecting pleural effusion or consolidations [10]. Molecular diagnostics, such as real-time RT-PCR for EHV-5 or equine influenza virus, can be performed on BALF to identify infectious agents [4, 17]. The integration of these data points allows for a definitive diagnosis and targeted therapy.

Therapeutic Monitoring

Serial BAL cytology is an effective tool for monitoring response to therapy. In severe asthma, successful therapy with corticosteroids (systemic or inhaled) is reflected by a significant reduction in neutrophil percentage in BALF [13, 9, 14, 29]. Roth et al. (2018) demonstrated that glucocorticosteroid administration is associated with an increase in regulatory T cells in the lungs, which correlates with the reduction in inflammation [13]. Similarly, bronchodilators like clenbuterol or salbutamol provide acute relief but do not alter the underlying cytological inflammation [21, 30]. Environmental management, including dust reduction and pasture turnout, is critical for long-term control and sustained normalization of BAL cytology [14, 22, 29]. In EIPH, the success of medical management (e.g., furosemide) or surgical intervention is monitored by the reduction in the degree of hemosiderosis on follow-up BAL [7, 11, 28]. Mahalingam-Dhingra et al. (2026) reported that nebulized lidocaine did not outperform saline in normalizing BAL cytology in asthmatic horses, highlighting the importance of evidence-based therapy [23].

Limitations and Challenges

While BAL cytology is highly informative, certain limitations must be acknowledged. The procedure is invasive and requires sedation and endoscopic expertise. Sample quality is operator-dependent; poor recovery due to airway collapse or inadequate wedging can lead to unrepresentative results [2, 3]. A common challenge is the contamination of BALF with squamous epithelial cells from the oropharynx, which indicates upper airway origin and renders the sample non-diagnostic for lower airway pathology [35]. The interpretation of cytological patterns also requires a skilled clinical pathologist, as subtle changes in cellular morphology and distribution can be missed. Furthermore, the normal reference ranges may vary between laboratories and with geographic location, necessitating the use of well-established in-house reference intervals [3, 1]. Finally, BAL cannot reliably distinguish between all etiologies; for example, a neutrophilic BAL can be seen in infection, severe asthma, and EMPF, necessitating further confirmatory testing [4, 35].

Future Directions

Advances in molecular biology are expanding the utility of BALF analysis beyond cytology. Gene expression profiling of BAL cells using RT-PCR or RNA sequencing provides a deeper understanding of the underlying inflammatory pathways [17, 16, 24]. Lipidomic and metabolomic profiling of BALF is revealing novel biomarkers of disease severity and response to therapy [19]. The development of automated image analysis algorithms for BAL cytology may improve standardization and throughput. Moreover, the incorporation of point-of-care molecular diagnostics for rapid pathogen identification could enhance the diagnostic value of BAL in infectious disease contexts [12, 4, 17]. The Mermaid diagram below outlines a decision tree for the diagnostic workup of equine respiratory disease using BAL cytology.

flowchart TD
    A[Clinical Signs: Cough, Dyspnea, Poor Performance], > B{Endoscopic Examination}
    B, > C[Normal or Mild Hyperemia]
    C, > D[BAL Cytology]
    D, > E{Cell Pattern}
    E, > F[Neutrophils <5%]
    E, > G[Neutrophils 5-10% or Eosinophils/Mast Cells >2%]
    E, > H[Neutrophils >25%]
    E, > I[Hemosiderophages +]
    E, > J[High Neutrophils + Degenerate + Bacteria]
    F, > K[Non-diagnostic / Normal]
    G, > L[Mild to Moderate Equine Asthma (IAD)]
    H, > M[Severe Equine Asthma (RAO)]
    I, > N[Exercise-Induced Pulmonary Hemorrhage]
    J, > O[Infectious Pneumonia]
    L, > P[Response to Therapy / Environmental Management]
    M, > P
    N, > Q[Management of Bleeding / Frusemide]
    O, > R[Culture + Sensitivity / Antibiotics]

Frequently Asked Questions

What is a normal neutrophil percentage in equine BAL fluid?

A normal neutrophil percentage in equine bronchoalveolar lavage fluid is less than 5% of total nucleated cells [3, 1]. Values between 5% and 10% may indicate mild to moderate equine asthma, while values exceeding 25% are characteristic of severe equine asthma (RAO) [6, 17].

How long after exercise should BAL be performed to diagnose EIPH?

To diagnose exercise-induced pulmonary hemorrhage, BAL should ideally be performed within 24 to 48 hours after strenuous exercise to detect erythrocytes and early hemosiderophages [7, 11]. However, hemosiderophages may persist in the airways for weeks, allowing for retrospective confirmation of EIPH [11].

Can BAL cytology distinguish between bacterial pneumonia and severe asthma?

BAL cytology alone cannot definitively distinguish between bacterial pneumonia and severe asthma, as both can present with a high percentage of neutrophils [35]. The presence of degenerate neutrophils, intracellular bacteria, and a positive bacterial culture are highly supportive of pneumonia, while severe asthma is typically associated with a high neutrophil count, abundant mucus, and a history of environmental triggers [6, 35].

Is there a role for BAL cytology in monitoring treatment response in asthmatic horses?

Yes, serial BAL cytology is a valuable tool for monitoring response to therapy in equine asthma [13, 9]. A reduction in neutrophil percentage following corticosteroid therapy and environmental management indicates an effective response [14, 29]. This objective measurement of airway inflammation can guide adjustments in medication and management protocols.

What are the main limitations of cytocentrifugation versus sediment smear preparations?

Cytocentrifugation provides a more uniform cell distribution and superior preservation of cellular morphology, making it the preferred method for accurate quantitative differential counts [6]. Sediment smears overrepresent larger cells and can cause cellular distortion, leading to imprecise neutrophil percentages. However, sediment smears can be useful for detecting rare cell types or hemosiderophages in samples with low total cell numbers [6].

References

[1] Tilley P, Sales Luis JP, Branco Ferreira M. Correlation and discriminant analysis between clinical, endoscopic, thoracic X-ray and bronchoalveolar lavage fluid cytology scores, for staging horses with recurrent airway obstruction (RAO). Res Vet Sci. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22136797/

[2] van Leenen K, Van Driessche L, De Cremer L, et al. Factors associated with lung cytology as obtained by non-endoscopic broncho-alveolar lavage in group-housed calves. BMC Vet Res. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31126282/

[3] Davis KU, Sheats MK. Bronchoalveolar Lavage Cytology Characteristics and Seasonal Changes in a Herd of Pastured Teaching Horses. Front Vet Sci. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30923711/

[4] Craven A, Todd-Donato A, Stokol T, et al. Clinical findings and outcome predictors for multinodular pulmonary fibrosis in horses: 46 cases (2009-2019). J Vet Intern Med. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38619130/

[5] Robins TJ, Bedenice D, Mazan M. A Longitudinal Analysis of Equine Asthma Presentation and Response to Treatment Using Lung Function Testing and BAL Cytology Analysis in Combination with Owner Perception. Animals (Basel). 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37958142/

[6] Morini M, Gobbo F, Rinnovati R, et al. Bronchoalveolar Lavage Cytology in Severe Equine Asthma: Cytocentrifugated versus Sediment Smear Preparations. Vet Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37624314/

[7] Perez-Moreno CI, Couëtil LL, Pratt SM, et al. Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses. Can Vet J. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19881919/

[8] Dupuis-Dowd F, Lavoie JP. Airway smooth muscle remodelling in mild and moderate equine asthma. Equine Vet J. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/34529300/

[9] Léguillette R, Tohver T, Bond SL, et al. Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease. J Vet Intern Med. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28568169/

[10] Schwarz B, Klang A, Bezdekova B, et al. Equine multinodular pulmonary fibrosis (EMPF): Five case reports. Acta Vet Hung. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23921344/

[11] Walker HJ, Evans DL, Slocombe RF, et al. Effect of corticosteroid and bronchodilator therapy

[12] Toner S, Leguillette R, Israel J, et al. Long-term follow-up of laryngeal Rhinosporidium seeberi diagnosed by PCR and treated with laser ablation and voriconazole nebulization in a retired thoroughbred polo horse. Can Vet J. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38952752/

[13] Boivin R, Vargas A, Cano P, et al. Glucocorticosteroids administration is associated with increased regulatory T cells in equine asthmatic lungs. Vet Immunol Immunopathol. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29914685/

[14] Barton AK, Shety T, Bondzio A, et al. Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction. BMC Vet Res. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27938355/

[15] Breuer J, Müller U, Locher L, et al. Differentiation of viable, apoptotic and necrotic cells in bronchoalveolar lavage fluid of normal horses and horses with recurrent airway obstruction. Berl Munch Tierarztl Wochenschr. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21462865/

[16] Beekman L, Tohver T, Dardari R, et al. Evaluation of suitable reference genes for gene expression studies in bronchoalveolar lavage cells from horses with inflammatory airway disease. BMC Mol Biol. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21272375/

[17] Padoan E, Ferraresso S, Pegolo S, et al. Real time RT-PCR analysis of inflammatory mediator expression in recurrent airway obstruction-affected horses. Vet Immunol Immunopathol. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/24176614/

[18] Lavoie JP, Thompson D, Hamilton E, et al. Effects of a MAPK p38 inhibitor on lung function and airway inflammation in equine recurrent airway obstruction. Equine Vet J. 2008. URL: https://pubmed.ncbi.nlm.nih.gov/19031513/

[19] Christmann U, Page AE, Horohov DW, et al. Lipidomic analysis of surfactant and plasma from horses with asthma and age-matched healthy horses. Am J Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35895773/

[20] Richard EA, Fortier GD, Denoix JM, et al. Influence of subclinical inflammatory airway disease on equine respiratory function evaluated by impulse oscillometry. Equine Vet J. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19562901/

[21] Bond SL, Greco-Otto P, MacLeod J, et al. Efficacy of dexamethasone, salbutamol, and reduced respirable particulate concentration on aerobic capacity in horses with smoke-induced mild asthma. J Vet Intern Med. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31953974/

[22] Gerber V, Schott Ii HC, Robinson NE. Owner assessment in judging the efficacy of airway disease treatment. Equine Vet J. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21592208/

[23] Mahalingam-Dhingra A, Bedenice D, South A, et al. An in-hospital clinical trial assessing nebulized lidocaine compared to saline for treatment of asthma in horses. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41742534/

[24] Hughes KJ, Nicolson L, Da Costa N, et al. Evaluation of cytokine mRNA expression in bronchoalveolar lavage cells from horses with inflammatory airway disease. Vet Immunol Immunopathol. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21194756/

[25] Barussi FC, Bastos FZ, Leite LM, et al. Intratracheal therapy with autologous bone marrow-derived mononuclear cells reduces airway inflammation in horses with recurrent airway obstruction. Respir Physiol Neurobiol. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27396936/

[26] Sandersen C, Olejnik D, Franck T, et al. Inhalation with NDS27 attenuates pulmonary neutrophilic inflammation in recurrent airway obstruction. Vet Rec. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21715367/

[27] Pearson W, Charch A, Brewer D, et al. Pilot study investigating the ability of an herbal composite to alleviate clinical signs of respiratory dysfunction in horses with recurrent airway obstruction. Can J Vet Res. 2007. URL: https://pubmed.ncbi.nlm.nih.gov/17479778/